Augmented migration of mesenchymal stem cells correlates with the subsidiary CXCR4 variant

References

• Nadig RR. Stem cell therapy - Hype or hope? A review. J Conservative Dentistry 2009;12:131–8. doi:10.4103/0972-0707.58329
   PubMedGoogle Scholar
• Via AG, Frizziero A, Oliva F. Biological properties of mesenchymal stem cells from different sources. Muscles Ligaments Tendons J 2012;2:154–62
   PubMedGoogle Scholar
• Zimmermann CE, Gierloff M, Hedderich J, et al. Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo. Tissue Engineering Part A 2011;17:1147–56. doi:10.1089/ten.tea.2009.0577
   PubMed Web of Science ®Google Scholar
• Eggenhofer E, Luk F, Dahlke MH, et al. The life and fate of mesenchymal stem cells. Front Immunol 2014;5:148. doi:10.3389/fimmu.2014.00148
   PubMed Web of Science ®Google Scholar
• Xing J, Hou T, Jin H, et al. Inflammatory microenvironment changes the secretory profile of mesenchymal stem cells to recruit mesenchymal stem cells. Cell Physiol Biochem 2014;33:905–19. doi:10.1159/000358663
   PubMed Web of Science ®Google Scholar
• Andreas K, Sittinger M, Ringe J. Toward in situ tissue engineering: chemokine-guided stem cell recruitment. Trends Biotechnol 2014;32:483–92. doi:10.1016/j.tibtech.2014.06.008
   PubMed Web of Science ®Google Scholar
• Pereira CL, Gonçalves RM, Peroglio M, et al. The effect of hyaluronan-based delivery of stromal cell-derived factor-1 on the recruitment of MSCs in degenerating intervertebral discs. Biomaterials 2014;35:8144–53. doi:10.1016/j.biomaterials.2014.06.017
   PubMed Web of Science ®Google Scholar
• Honczarenko M, Le Y, Swierkowski M, et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells (Dayton, Ohio) 2006;24:1030–41. doi:10.1634/stemcells.2005-0319
   PubMed Web of Science ®Google Scholar
• Naderi-Meshkin H, Bahrami AR, Bidkhori HR, et al. Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy. Cell Biol Int 2015;39:23–34. doi:10.1002/cbin.10378
   PubMed Web of Science ®Google Scholar
• Andreas K, Sittinger M, Ringe J. Toward in situ tissue engineering: chemokine-guided stem cell recruitment. Trends Biotechnol 2014;32:483–92. doi:10.1016/j.tibtech.2014.06.008
   PubMed Web of Science ®Google Scholar
• Schulte A, Gunther HS, Phillips HS, et al. A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target. Glia 2011;59:590–602. doi:10.1002/glia.21127
   PubMed Web of Science ®Google Scholar
• Vagima Y, Lapid K, Kollet O, et al. Pathways implicated in stem cell migration: the SDF-1/CXCR4 axis. Methods Mol Biol 2011;750:277–89. doi:10.1007/978-1-61779-145-1_19
   PubMedGoogle Scholar
• Ma J, Liu N, Yi B, et al. Transplanted hUCB-MSCs migrated to the damaged area by SDF-1/CXCR4 signaling to promote functional recovery after traumatic brain injury in rats. Neurol Res 2015;37(1):50–56
   PubMed Web of Science ®Google Scholar
• Saito Y, Shimada M, Utsunomiya T, et al. Homing effect of adipose-derived stem cells to the injured liver: the shift of stromal cell-derived factor 1 expressions. J Hepato-Biliary-Pancreatic Sci 2014;21(12):873–80
   PubMed Web of Science ®Google Scholar
• Delongchamps NB, Beuvon F, Mathieu JR, et al. CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers. World J Urol 2015;33(2):281–7
   PubMed Web of Science ®Google Scholar
• Trautmann F, Cojoc M, Kurth I, et al. CXCR4 as biomarker for radioresistant cancer stem cells. Int J Rad Biol 2014;90:687–99
   PubMed Web of Science ®Google Scholar
• Jin F, Brockmeier U, Otterbach F, et al. New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation. Mol Cancer Res 2012;10:1021–31
   PubMed Web of Science ®Google Scholar
• Krebs MG, Metcalf RL, Carter L, et al. Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol 2014;11:129–44
   PubMed Web of Science ®Google Scholar
• Ullah M, Eucker J, Sittinger M, et al. Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum. Stem Cell Res Ther 2013;4:99
   PubMed Web of Science ®Google Scholar
• Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 2003;17:160–70
   PubMed Web of Science ®Google Scholar
• Naderi-Meshkin H, Matin MM, Heirani-Tabasi A, et al. Injectable hydrogel delivery plus preconditioning of mesenchymal stem cells: exploitation of SDF-1/CXCR4 axis towards enhancing the efficacy of stem cells' homing. Cell Biol Int 2016;40(7):730–41
   PubMed Web of Science ®Google Scholar
• Gupta SK, Pillarisetti K. Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant. J Immunol 1999;163:2368–72
   PubMed Web of Science ®Google Scholar
• Duquenne C, Psomas C, Gimenez S, et al. The Two Human CXCR4 isoforms display different HIV receptor activities: Consequences for the emergence of X4 Strains. J Immunol 2014;193:4188–94
   PubMed Web of Science ®Google Scholar
• Bae S, Jeong HJ, Cha HJ, et al. The hypoxia-mimetic agent cobalt chloride induces cell cycle arrest and alters gene expression in U266 multiple myeloma cells. Int J Mol Med 2012;30:1180–6
   PubMed Web of Science ®Google Scholar
• Ramesh Reddy B, Kloner RA, Przyklenk K. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. Free Radical Biol Med 1989;7:45–52
   PubMed Web of Science ®Google Scholar
• Hao H-H, Wang L, Guo Z-J, et al. Valproic acid reduces autophagy and promotes functional recovery after spinal cord injury in rats. Neuroscience Bulletin 2013;29:484–92
   PubMed Web of Science ®Google Scholar
• De Clercq E. The bicyclam AMD3100 story. Nat Rev Drug Discov 2003;2:581–7
   PubMed Web of Science ®Google Scholar
• Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 2008;45:514–22
   PubMed Web of Science ®Google Scholar
• Henschler R, Deak E, Seifried E. Homing of mesenchymal stem cells. Transfusion Med Hemotherapy 2008;35:7
   Web of Science ®Google Scholar
• Viswanathan A. Enhanced expression of N-formyl peptide receptor in mesenchymal stem cells facilitates homing to inflammatory lungs. J Genet Syndr Gene Therapy 2014;05:227
   Google Scholar
• Ge J, Hu Y, Gui Y, et al. Chemotherapy-induced alteration of SDF-1/CXCR4 expression in bone marrow–derived mesenchymal stem cells from adolescents and young adults with acute lymphoblastic leukemia. J Pediatric Hematol/Oncol 2014;36:617–23
   PubMed Web of Science ®Google Scholar
• Lau TT, Wang DA. Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Exp Opin Biol Ther 2011;11:189–97
   PubMed Web of Science ®Google Scholar
• Bobis-Wozowicz S, Miekus K, Wybieralska E, et al. Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. Exp Hematol 2011;39:686–96 e4
   PubMed Web of Science ®Google Scholar
• Kean TJ, Lin P, Caplan AI, et al. MSCs: Delivery routes and engraftment, cell-targeting strategies, and immune modulation. Stem Cells Int 2013;2013:732742
   PubMed Web of Science ®Google Scholar
• Gupta SK, Pillarisetti K. Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant. J Immunol 1999;163:2368–72
   PubMed Web of Science ®Google Scholar
• Hung S-C, Pochampally RR, Hsu S-C, et al. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One 2007;2(5):e416
   PubMed Web of Science ®Google Scholar
• Hou Z, Nie C, Si Z, et al. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1alpha. Diabetes Res Clin Pract 2013;101(1):62–71
   PubMed Web of Science ®Google Scholar
• Yu X, Lu C, Liu H, et al. Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. PLoS One 2013;8:e62703, PONE-D-12-39161 [pii]
   PubMed Web of Science ®Google Scholar
• Wiehe J, Kaya Z, Homann J, et al. GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair. Int J Cardiol 2013;167:2073–81
   PubMed Web of Science ®Google Scholar
• Secco M, Zucconi E, Vieira NM, et al. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells 2008;26:146–50
   PubMed Web of Science ®Google Scholar
• da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells (Dayton, Ohio) 2008;26:2287–99
   PubMed Web of Science ®Google Scholar
• Liu H, Xue W, Ge G, et al. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs. Biochem Biophys Res Commun 2010;401:509–15
   PubMed Web of Science ®Google Scholar
• Yamanegi K, Yamane J, Kobayashi K, et al. Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas-and NK cell-mediated cell death. Int J Oncol 2012;41:83–91
   PubMed Web of Science ®Google Scholar
• Ganju RK, Brubaker SA, Meyer J, et al. The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 1998;273:23169–75
   PubMed Web of Science ®Google Scholar